What is Epitalon?
Epitalon (also spelled Epithalon) is the tetrapeptide Ala-Glu-Asp-Gly. It has been studied in ageing-related laboratory research, including chromatin, telomerase and cellular proliferation.
Proposed mechanism
Cell studies report effects on telomerase-related pathways, chromatin state and gene expression. These findings are mechanistic observations, not proof that Epitalon slows ageing or extends human lifespan.
What has been published?
Older studies reported telomere-related effects in cultured human cells, and a 2025 study found increased telomere length in several human cell lines through telomerase or alternative-lengthening activity.
Current human evidence
There is no modern, large, independently replicated randomized trial showing that Epitalon extends healthy lifespan or meaningfully reduces age-related disease in humans.
Regulatory status
Epitalon is not an FDA-approved anti-ageing or longevity treatment.
Possible areas of research interest
- Telomere biology
- Cellular ageing
- Chromatin regulation
- Gene-expression research
Important limitations
- Cell-culture findings are often overstated online
- Longevity claims lack robust clinical validation
- Independent replication is limited
- Long-term human safety and efficacy remain uncertain
References
AEVLI prioritizes primary publications and regulator materials over anecdotal claims.